Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial

Authors:

Abstract
No abstract available
Funding Information
  • Sanifit Therapeutics, S.A

This publication has 14 references indexed in Scilit: